Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Gynaecol Oncol ; 34(6): 545-7, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24601048

RESUMO

PURPOSE: To assess the prevalence of leiomyomas in patients with endometrial carcinoma (EC) and the association of their presence with clinico-pathological variables and with survival. MATERIALS AND METHODS: A retrospective chart review was conducted of all endometrial carcinoma (EC) patients diagnosed and treated in the present institution between 2002 and 2008. Selected clinical data were abstracted from medical records. Pathological data such as the presence of myomas (any size), tumor grade, depth of myometrial invasion presence of lymphovascular space involvement (LVSI), and the presence of metastases, are based on the original pathology report. RESULTS: Coexisting myomas were found in 74 (56.9%) of 130 EC patients diagnosed during the study period. No significant difference with regard to age, histological type, stage, grade, depth of myometrial invasion, LVSI, lymph node involvement, and presence of metastases (other than lymph node involvement) was found between patients without and with myomas. There was also no significant difference in survival of EC patients without and with coexistent myomas. CONCLUSION: The present data seem to indicate that the presence of myomas does not affect clinico-pathological variables of EC patients nor their survival.


Assuntos
Carcinoma/secundário , Neoplasias do Endométrio/patologia , Leiomioma/diagnóstico , Neoplasias Primárias Múltiplas/patologia , Vasos Sanguíneos/patologia , Feminino , Humanos , Metástase Linfática , Vasos Linfáticos/patologia , Pessoa de Meia-Idade , Gradação de Tumores , Invasividade Neoplásica , Estadiamento de Neoplasias , Neoplasias Primárias Múltiplas/diagnóstico , Estudos Retrospectivos , Taxa de Sobrevida
2.
Int J Gynecol Cancer ; 12(4): 372-5, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12144685

RESUMO

Serum CA125 is elevated in some endometrial cancer patients. The purpose of the present study was to assess the correlation between the presence of CA125 in endometrial cancer tissue and elevated CA125 serum levels. Serum levels of CA125 were examined in 39 patients with endometrial cancer prior to definitive surgery. After diagnosis reconfirmation, additional slides were prepared from each case for immunohistochemical staining for anti-CA125 antigens. Of the 39 patients, 28 had endometrioid endometrial carcinoma (EEC) and 11 had mixed mesodermal sarcoma (MMS). In EEC, 21.4% of the patients had an elevated CA125 serum level, and that correlated with stage (P = 0.02) but not with grade. The percentage of EEC patients with positive tissue staining was significantly higher than the percentage with elevated serum levels (89.3% vs. 21.4%, P < 0.0001). No correlation between positive tissue staining and stage or grade was observed. In MMS the percentage of positive tissue staining was also higher than that with elevated serum CA125 levels and the percentage with elevated serum levels was higher than in EEC. However, the differences were statistically not significant. Our study indicates that the majority of EEC tissues contain CA125 and that the percentage of positive CA125 tissue staining is significantly higher than that of elevated CA125 serum levels. This indicates the presence of some mechanism that prevents the access of CA125 into the circulation. This mechanism is probably less effective in more advanced EEC's and in MMS.


Assuntos
Biomarcadores Tumorais/metabolismo , Antígeno Ca-125/metabolismo , Carcinoma Endometrioide/sangue , Neoplasias do Endométrio/sangue , Sarcoma/sangue , Idoso , Biomarcadores Tumorais/sangue , Antígeno Ca-125/sangue , Feminino , Humanos , Imuno-Histoquímica , Estadiamento de Neoplasias , Valor Preditivo dos Testes
3.
Eur J Obstet Gynecol Reprod Biol ; 67(2): 139-41, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8841802

RESUMO

OBJECTIVE: To assess the effect of steroids administered for the enhancement of fetal lung maturation on uterine activity. DESIGN: A retrospective analysis. SETTING: High-risk Pregnancy Unit, Golda Medical Center, Petah Tikvah, Israel. PATIENTS: Fifty-nine courses of betamethasone therapy prescribed for various indications other than premature contractions were studied in 29 pregnant women at 26-34 weeks' gestation. MEASUREMENTS: Uterine activity was monitored on the day of the first (but prior to) beta-methasone injection, then daily for the next 3 consecutive days. The number of uterine contractions during the first 30 min of each tocodynamometric tracing was assessed. RESULTS: The frequency of uterine activity after steroid administration is significantly higher in multiple pregnancies as compared to singletons, and significantly increases as the duration of pregnancy increases. However, labor was not induced and all women delivered at least 1 week after the last betamethasone injection. CONCLUSIONS: Since the increased uterine activity after administration of steroids for the enhancement of fetal lung maturation does not provoke labor, it is suggested that this increase in uterine activity seems to act as a temporary phenomenon. Therefore conservative management, rather than tocolysis, would seem appropriate.


Assuntos
Anti-Inflamatórios/farmacologia , Betametasona/farmacologia , Desenvolvimento Embrionário e Fetal/fisiologia , Pulmão/embriologia , Útero/efeitos dos fármacos , Útero/fisiologia , Adulto , Relação Dose-Resposta a Droga , Desenvolvimento Embrionário e Fetal/efeitos dos fármacos , Feminino , Humanos , Gravidez , Estudos Retrospectivos , Contração Uterina/efeitos dos fármacos , Contração Uterina/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...